REPL vs WAT
Replimune Group Inc (REPL) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported WAT revenue for 2024-12-31 was $872.7M. Net income was $637.8M. Revenue was up 17.9% from 2024-09-30 to 2024-12-31. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
REPL currently screens at market cap $825.7M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the REPL and WAT stock pages for the full models.
Not investment advice.